Hospitals and clinics continue to face a central challenge: extensive cardiac testing still fails to deliver clear, consistent diagnostic answers, slowing decision‑making and creating downstream operational and financial strain. In this episode, Jim Hartman, Chief Commercial Officer at Cleerly, examines with host Marilie Fouché how AI‑driven coronary CTA analysis strengthens diagnostic certainty, streamlines workflows across radiology, cardiology, and the cath lab, and supports more defensible adoption decisions for clinical and operational leaders. The discussion highlights practical evaluation criteria — clinical impact, workflow efficiency, and financial return — that executives can use to assess whether advanced imaging technologies can be integrated and scaled within their organizations. This episode is sponsored by Cleerly. Learn how to identify AI trends by tracking where venture funding is flowing, and by listening to how leading CEOs describe risk and competitive strategy, download our free PDF report, "3 Ways to Discover AI Trends in Any Sector" at emerj.com/ait1

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related